Fresh2 Group Ltd Asset Turnover Ratio (ANPC), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Fresh2 Group Ltd  (NASDAQ: ANPC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Fresh2 Group Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2022, Fresh2 Group Ltd's asset turnover ratio sequentially decreased to 0.06 in the fourth quarter (Dec 31 2022), this is lower than usual.

Within sector 30 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 0 to 3170.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANPC Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change 1281.64 % -84.22 % -68.96 % 112.86 % -20.02 %
Y / Y Revenue Change -38.13 % - - - -
Asset Turnover Ratio (TTM) 0.06 - - - 0.13
ANPC's Total Ranking # 3170 # 0 # 3962 # 0 # 0
Seq. Asset Change 900.8 % 38.05 % -63.35 % 172.89 % -88.57 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 31
Healthcare Sector # 442
Overall Market # 3170

Asset Turnover Ratio Statistics
High Average Low
0.3 0.3 0.3
(Dec 31 2022)  




ANPC Company Profile • Back to ANPC Efficiency Comparisons • Compare ANPC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Femasys Inc   0.06 $ 1.206  Millions$ 21.396  Millions
Northwest Biotherapeutics Inc  0.06 $ 1.683  Millions$ 30.150  Millions
Armata Pharmaceuticals Inc   0.06 $ 5.508  Millions$ 99.366  Millions
Meiragtx Holdings Plc  0.05 $ 15.920  Millions$ 289.951  Millions
Tango Therapeutics Inc   0.05 $ 24.860  Millions$ 455.138  Millions
Scorpius Holdings inc   0.05 $ 6.383  Millions$ 117.671  Millions
Tenon Medical Inc   0.05 $ 0.691  Millions$ 12.825  Millions
Greenlight Biosciences Holdings Pbc  0.05 $ 6.780  Millions$ 130.314  Millions
Asensus Surgical Inc   0.05 $ 7.087  Millions$ 139.654  Millions
Rhythm Pharmaceuticals Inc   0.05 $ 16.884  Millions$ 333.649  Millions
Streamex Corp   0.05 $ 0.286  Millions$ 5.706  Millions
Soligenix inc   0.05 $ 0.949  Millions$ 19.304  Millions
Altamira Therapeutics Ltd   0.05 $ 0.306  Millions$ 6.303  Millions
Therapeutic Solutions International Inc   0.05 $ 0.207  Millions$ 4.280  Millions
Revolution Medicines Inc   0.05 $ 35.380  Millions$ 738.354  Millions
Ascendis Pharma A  0.05 $ 57.315  Millions$ 1,220.507  Millions
Intellipharmaceutics International Inc   0.05 $ 0.066  Millions$ 1.432  Millions
Scynexis Inc   0.05 $ 5.091  Millions$ 111.819  Millions
Bellicum Pharmaceuticals Inc   0.05 $ 1.538  Millions$ 33.786  Millions
Infinity Pharmaceuticals Inc   0.05 $ 2.593  Millions$ 57.044  Millions
Beam Therapeutics Inc   0.04 $ 60.920  Millions$ 1,390.935  Millions
Hyperfine Inc   0.04 $ 6.814  Millions$ 155.729  Millions
Baudax Bio Inc   0.04 $ 1.269  Millions$ 29.297  Millions
Foghorn Therapeutics Inc   0.04 $ 19.228  Millions$ 446.005  Millions
Stoke Therapeutics Inc   0.04 $ 12.405  Millions$ 287.765  Millions
Exscientia Plc  0.04 $ 33.678  Millions$ 784.574  Millions
Intellia Therapeutics Inc   0.04 $ 52.121  Millions$ 1,229.446  Millions
Celularity Inc   0.04 $ 17.975  Millions$ 425.430  Millions
Xoma Royalty Corporation  0.04 $ 6.027  Millions$ 149.974  Millions
Lexaria Bioscience Corp   0.04 $ 0.343  Millions$ 9.055  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.